Description
Imatinib mesylate is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells). This is how it works to stop or slow the spread of cancer.
Common side effects of Imatinib mesylate
Abdominal pain, Diarrhea, Edema (swelling), Fatigue, Muscle cramp, Musculoskeletal (bone, muscle or joint) pain, Nausea, Rash, Vomiting
